Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?
Journal of Biomedical Science and Engineering
doi 10.4236/jbise.2018.114006
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Scientific Research Publishing, Inc.